Abstract

Covid-19 has brought unexpected social, political, and economic interruptions to the world, causing endless suffering to people’s lives. As of 19 December 2021, Covid-19 has taken away more than 5 million lives and infected more than 274 million people worldwide. Although many medicines are tested, there is barely any reliable and effective treatment found. The only hope to get out of this pandemic remains concentrated on “Vaccines”. As the nations develop and distribute the Covid-19 vaccines, a potential threat becomes the utilization of vaccine distribution as a soft power tool. So, the major challenge this pandemic has brought is securing vaccine procurement worldwide. Bangladesh, the south Asian developing country, faced a vaccine shortage too. It had to go through various geopolitical struggles and diplomacies to procure vaccines. The fundamental purpose of this study is to review the vaccine procurement opportunities and their relation to the contemporary geopolitical paradigm of Bangladesh. Relevant works of literature consist of journal articles, government statements from multiple countries are reviewed throughout the case. From the beginning to the end of the case, it has been observed that there was a geopolitical power demonstration between India and China regarding the Covid-19 vaccine distribution in Bangladesh. The strong political relation with China, effective diplomacy with the US Biden administration, and a successful diplomatic effort in Japan finally helped Bangladesh to procure a sufficient vaccine for the moment. The research is significant because it connects the pandemic and geopolitics. Although the Covid-19 pandemic is stated as a humanitarian crisis by the great nations, it is clear that it has become an opportunity for many to influence the geopolitical paradigm. If the pandemic has to end, it is vital to distribute vaccines equally throughout the world. The research finds a relation of geopolitical influence with vaccine procurement which destroys equality and reduces the chance of ending the pandemic. This research will bring attention to this important issue in front of the world. In addition, based on this study, other in-depth research could be formed to reduce this global problem.

Keywords: Bangladesh, Covid-19, China Vaccine, India, Geopolitics, Pandemic, Procurement.

JEL Classification: I14, I18.

Cite as: Ahmed, K.M.F. (2021). Procuring Covid-19 Vaccine and the Contemporary Geopolitical Paradigm for Bangladesh. Business Ethics and Leadership, 5(4), 118-126. https://doi.org/10.21272/bel.5(4).118-126.2021

This work is licensed under a Creative Commons Attribution 4.0 International License

References

1. Arora, N., Jain, R. (2021). India hopes U.S. Will Soon Ease Ban on Vaccine Material Exports. Reuters. 19 April. Available at: [Link]
2. Air News (2021). Controversy over disclosure of Chinese COVID vaccine pricing in Bangladesh. News on air. Available at: [Link]
3. . Remdesivir for the treatment of Covid19-preliminary report. The New English Journal of Medicine [Internet], 383, 1813-1826. [CrossRef]
4. The BBC (2021). Coronavirus: India Temporarily Halts Oxford-AstraZeneca Vaccine Exports. Available online at: [Link]
5. BBC (2021b). Bangladesh eyes Sputnik vaccine to overcome supply shortage from India, BBC news. Available at: [Link]
6. Bhattacherjee, K. (2020). India to offer COVID-19 vaccine to Bangladesh on priority basis. The Hindu. Available at: [Link]
7. Bishay, N. (2021). COVID-19: Bangladesh Receives 2.5 Million Doses Of Moderna Vaccine From US. Republic World. Available at: [Link]
8. Chaudhury, D. R. (2020). China plans to use Bangladesh population to conduct phase III Covid-19 vaccine trails. The Economic Times. Available at: [Link]
9. Covid19 vaccine Dashboard (2021). COVID-19 Vaccination Dashboard for Bangladesh. Bangladesh Government [Official website]. Available at: [Link]
10. Daria, S. et al. (2021). The massive attack of COVID-19 in India is a big concern for Bangladesh: The key focus should be given on the interconnection between the countries. Wiley [Online]. [Google Scholar] [CrossRef]
11. Dasgupta, D. (2020). India tries vaccine diplomacy with Bangladesh, close on heels of China. The Straits Times. Available at: [Link]
12. Dhaka Tribune (2021b). How did Bangladesh get Covid-19 vaccine so quickly? Dhaka Tribune. Available at: [Link]
13. Dhaka Tribune (2021d). 8.6 million doses of Covid-19 vaccine administered in Bangladesh. Dhaka Tribune. Available at: [Link]
14. Dhaka Tribune (2021h). China to send 600,000 more Covid vaccine doses to Bangladesh by June 13. Dhaka Tribune. Available at: [Link]
15. Dhaka Tribune (2021i). Bangladesh approves Sinovac Covid-19 vaccine for emergency use. Dhaka Tribune. Available at: [Link]
16. DD news (2021). Japan sends 2.45 lakh AstraZeneca COVID vaccines to Bangladesh, 3 million doses to follow. DD news. Available at: [Link]
17. Fonseca, E.Md. et al. (2021). The politics of COVID-19 vaccination in middle-income countries: Lessons from Brazil. Social science and medicine, 281, 114093. [Google Scholar] [CrossRef]
18. Gupta, S. (2020). Bangladesh’s Beximco Signs New COVID Vaccine Deal With India’s SII to Ensure Priority Access. India.com. Available at: [Link]
19. Gentleman, J., Venugopal S., Mandavilli, A. (2021). India Blames Covid-19 Variant for its Pandemic Crisis. The New York Times. Available at: [Link]
20. Hasan, A.M. (2021). China Swoops into Bangladesh with a Vaccine Deal. The Diplomat [Online]. Available at: [Link]
21. Hindustan Times (2021a). Bangladesh appeals to world community for Covid-19 vaccine doses. Business Standard. Available at: [Link]
22. Jieliang Wang et al. (2020). The COVID-19 Vaccine Race: Challenges and Opportunities in Vaccine Formulation. AAPS PharmSciTech, 21(6). [Google Scholar] [CrossRef]
23. Joi, P. (2021). Gavi the Vaccine Alliance. Why is India’s COVID-19 Pandemic Skyrocketing. Available at: [Link]
24. Lan, J., Ge, J., Yu, J., Shan, S., Zhou, H., Fan, S., et al. (2020). Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature, 581(7807), 215-220. [Google Scholar] [CrossRef]
25. Lambert, R., Shah, C., Weiner, J. (2021). The Distribution of COVID-19 Vaccines: A Geopolitical and Strategic Analysis of Southeast Asia. Available at: [Link]
26. Mortoza, G. (2021). Vaccines Under Covax: Helping homeland in hour of need. The Daily Star. Available at: [Link]
27. Ministry of Health and Family Welfare (2021). Dashboard. Available at: [Link]
28. Paul, R. (2020). Bangladesh’s Beximco Signs COVID-19 Vaccine Deal With India’s Serum Institute. US News (The Reuters). Available at: [Link]
29. Pandey, V., Nazmi, S. (2021). India Coivd-19: Deadly Second Wave Spreads from Cities to Small Towns. The BBC. Available online at: [Link]
30. Prothom Alo (2020a). When can actually Bangladesh avail of COVID-19 vaccine? The Daily Prothom Alo. Available at: [Link]
31. Prothom Alo (2021b). China criticizes Bangladesh’s indecision over Covid vaccine. Prothom Alo. Available at: [Link]
32. Reuters (2020). Bangladesh signs deal with India for 30 million doses of covid19 vaccines. The times of India. Available at: [Link]
33. Reuters (2021). Nepal, Bangladesh scramble to secure COVID-19 shots as India curbs exports. Reuters. Available at: [Link]
34. Rahman, A. (2021). Bangladesh receives first covid-19 vaccine consignment from India. Available at: [Link]
35. Sumon, S. (2021b). Bangladesh joins global COVID-19 vaccine race with Bangavax set for clinical trial. Arab News. Available at: [Link]
36. Sakib, S.N. (2021). Moderna vaccine gets approval in Bangladesh. AA News. Available at: [Link]
37. The new Indian express (2020a). India’s COVID-19 vaccine in advanced stage, Bangladesh to get it on priority: Foreign secretary Shringla. Available at: [Link]
38. The economic Times (2020a). Chinese pharmaceutical firm seeks Bangladesh co-finance for COVID-19 vaccine trials. The economic times. Available at: [Link]
39. The Daily Star (2021d). Purchase of Sinopharm Vaccine: Price disclosure sparks confusion. The Daily Star. Available at: [Link]
40. The Daily Star (2021f). Sinopharm Shots: 2nd shipment of 6 lakh to arrive by June 13. The Daily Star. Available at: [Link]
41. The Daily Star (2021g). Moderna gets emergency use authorization in Bangladesh. The Daily Star. Available at: [Link]
42. The Times of India (2021). Covid-19: India Records Highest-Ever 401,993 New Cases, 3523 Deaths. Available online at: [Link].
43. Times of India (2021b). Expensive Chinese vaccines stir hornet’s nest in Bangladesh, Sri Lanka. The Times of India. Available at: [Link]
44. The Hindu (2021a). Bangladesh receives 5,00,000 doses of Chinese COVID-19 vaccine as gift. The Hindu. Available at: [Link]
45. The Visual and Data Journalism Team (2021). Covid map: coronavirus cases, deaths, vaccinations by country (BBC). Available at: [Link]
46. The Independent Panel (2021). Fifth Meeting of the Panel Meeting Report. The Independent Panel. Available at: [Link]
47. Vaccines given in Bangladesh (Covid19 vaccine Dashboard) (2021). All vaccine 1st dose administered over time. Available at: [Link]
48. Vaccines given in Bangladesh (Covid19 vaccine Dashboard) (2021). All vaccine 2nd dose administered over time. Available at: [Link]
49. Vankovska, B. (2021). Geopolitics of Vaccines: War with other Means? Available at: [Link]
50. World Bank (2021). Global Economic Prospects. Available at: [Link]
51. Wu, F., Zhao, S., Yu, B., Chen, Y., Wang, W., Song, Z., et al. (2020). A new coronavirus associated with human respiratory disease in China. Nature [Internet], 579(7798), 265-269. [Google Scholar]
52. Wang, Y., Zhang, D., Du, G., Du, R., Zhao, J. Jin Y., et al. (2020). Remdesivir in adults with severe COVID-19: a randomized, double-blind, placebo-controlled, multicenter trial. Lancet [Internet]. Available at: [Link]
53. Xinhua (2021a). Bangladesh to administer 2nd COVID-19 vaccine dose from April. Available at: [Link]